Provectus Biopharmaceuticals, Inc. (PVCT)

PVCT Revenue

In the year 2024, Provectus Biopharmaceuticals had annual revenue of $617.14K with 10.66% growth. Provectus Biopharmaceuticals had revenue of $14.33K in the quarter ending December 31, 2024, a decrease of -88.17%.

• Revenue: 617.14K
• Revenue Growth: +10.66%
• P/S Ratio: 65.42
• Revenue / Employee: 102.86K
• Employees: 6
• Market Cap: 40.37M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	617.14K	59.43K	10.66%
Dec 31, 2023	557.71K	-431.33K	-43.61%
Dec 31, 2022	989.04K	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-